224 related articles for article (PubMed ID: 37621159)
1. Photo-Induced Cross-Linking of Unmodified α-Synuclein Oligomers.
Ortigosa-Pascual L; Leiding T; Linse S; Pálmadóttir T
ACS Chem Neurosci; 2023 Sep; 14(17):3192-3205. PubMed ID: 37621159
[TBL] [Abstract][Full Text] [Related]
2. Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides.
Rahimi F; Maiti P; Bitan G
J Vis Exp; 2009 Jan; (23):. PubMed ID: 19229175
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).
Williams TL; Serpell LC; Urbanc B
Biochim Biophys Acta; 2016 Mar; 1864(3):249-259. PubMed ID: 26699836
[TBL] [Abstract][Full Text] [Related]
4. Application of photochemical cross-linking to the study of oligomerization of amyloidogenic proteins.
Lopes DH; Sinha S; Rosensweig C; Bitan G
Methods Mol Biol; 2012; 849():11-21. PubMed ID: 22528080
[TBL] [Abstract][Full Text] [Related]
5. Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins.
Bitan G
Methods Enzymol; 2006; 413():217-36. PubMed ID: 17046399
[TBL] [Abstract][Full Text] [Related]
6. The early events of alpha-synuclein oligomerization revealed by photo-induced cross-linking.
Li HT; Lin XJ; Xie YY; Hu HY
Protein Pept Lett; 2006; 13(4):385-90. PubMed ID: 16712515
[TBL] [Abstract][Full Text] [Related]
7. Cross-Linked α-Synuclein as Inhibitor of Amyloid Formation.
Murvai N; Gellen G; Micsonai A; Schlosser G; Kardos J
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686208
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for preventing α-synuclein aggregation by a molecular tweezer.
Acharya S; Safaie BM; Wongkongkathep P; Ivanova MI; Attar A; Klärner FG; Schrader T; Loo JA; Bitan G; Lapidus LJ
J Biol Chem; 2014 Apr; 289(15):10727-10737. PubMed ID: 24567327
[TBL] [Abstract][Full Text] [Related]
9. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
10. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in Solution.
Awasthi S; Ying C; Li J; Mayer M
ACS Nano; 2023 Jul; 17(13):12325-12335. PubMed ID: 37327131
[TBL] [Abstract][Full Text] [Related]
12. Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies.
Bitan G; Teplow DB
Acc Chem Res; 2004 Jun; 37(6):357-64. PubMed ID: 15196045
[TBL] [Abstract][Full Text] [Related]
13. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.
Ono K; Takasaki J; Takahashi R; Ikeda T; Yamada M
J Neurosci Res; 2013 Oct; 91(10):1371-81. PubMed ID: 23913715
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative.
Chau E; Kim H; Shin J; Martinez A; Kim JR
Biochem Biophys Res Commun; 2021 Oct; 574():85-90. PubMed ID: 34454326
[TBL] [Abstract][Full Text] [Related]
16. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
Alam P; Bousset L; Melki R; Otzen DE
J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the non-fibrillar α-synuclein oligomers.
Hong DP; Han S; Fink AL; Uversky VN
Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
[TBL] [Abstract][Full Text] [Related]
18. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins.
Bitan G; Lomakin A; Teplow DB
J Biol Chem; 2001 Sep; 276(37):35176-84. PubMed ID: 11441003
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
